Registry of Lobbyists
| Corporation: | AstraZeneca Canada Inc. |
| Associated registration: | 949884-15042-56 |
| Communication date: | 2023-12-12 |
| Posted date: | 2024-01-29 |
| Designated Public Office Holders who participated in the communication: |
Joel Denis,
Director General
Medical Countermeasures Programming, Public Health Agency of Canada (PHAC) Heather Jeffrey, President Public Health Agency of Canada (PHAC) Erin Schock, Director National Laboratory, Public Health Agency of Canada (PHAC) Cindy Evans, Vice-President Emergency Management Branch, Public Health Agency of Canada (PHAC) |
| Subject Matter of the communication: | Industry |
| Communication Report amended on: | 2024-01-29 previous entry: 15042-590029 |
| Reason for amendment: | Email received January 29 - The following potential discrepancy was brought to our attention during a confirmation of lobbying activity information undertaken by this office under subsection 9.1(1) of the Lobbying Act: we were advised that Cindy Evans's position title is incorrect. Please take a moment to amend the position title to "Cindy Evans, Vice President, Emergency Management Branch, Public Health Agency of Canada." |
| Responsible Officer who filed this communication report: | Kiersten Combs |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |